An analysis by the Wall Street Journal of healthcare spend over the past several decades reveals the price of healthcare continues to increase faster than the consumer price index, with health spending primarily driven by hospital and physician services.
In … Continue Reading
Unilife Corp. has announced it has secured $60 million in debt financing.
Unilife, headquartered in York, Pa., is a developer and supplier of injectable drug delivery systems.
The financing will come from an affiliate of OrbiMed, a New … Continue Reading
Republicans in the House are expected to vote this week on legislation that would permanently repeal the sustainable growth rate (SGR) Medicare physician payment formula.
To pay for the SGR fix, the legislation is expected to propose a delay or … Continue Reading
We have previously discussed on this blog the ever-increasing federal and state focus on healthcare fraud prevention and enforcement activities.
As investors consider opportunities, especially those in more highlighted areas of sensitivity, they should be aware of the government’s focus … Continue Reading
OIG recently released its Work Plan for fiscal year 2014, and it includes a number of planned areas of focus for investigation and enforcement activities in the coming year that should be of interest to healthcare investors.
To access a … Continue Reading
Cheetah Medical has announced it has raised $9 million in financing.
Cheetah Medical, based in Newton Center, Mass., is a developer of non-invasive hemodynamic monitoring, including the CHEETAH NICOM hemodynamic management system.
Leading the investment round was Fletcher Spaght … Continue Reading
DaVita HealthCare Partners has announced in an earnings call with shareholders that it will settle federal anti-kickback investigations into some of the company’s relationships with nephrologists, according to a Denver Post report.
Under the terms of the settlement, Denver-based … Continue Reading
Congressional lawmakers have reached a bipartisan agreement that would repeal and replace the sustainable growth rate (SGR) Medicare physician payment formula, according to a Modern Healthcare report.
Under the new system, physicians will receive a 0.5 percent pay increase … Continue Reading
Every year since 2002, Congress has postponed the Medicare physician payment cuts that would be triggered by the sustainable growth rate (SGR) formula. But there is optimism that 2014 may finally be the year when the SGR is repealed and … Continue Reading
By Geoff Cockrell, Steven Keeler and Clare Lewis
Earlier in the year, CB Insights reported that the syndicate patterns of the most active tech VC investors revealed a host of co-investor relationships, overlapping investing strategies and/or geographic focus areas. In … Continue Reading
Quest Diagnostics has announced it has entered into a definitive agreement to acquire Solstas Lab Partners Group and its subsidiaries for approximately $570 million.
Solstas, a commercial laboratory company based in Greensboro, N.C., is a portfolio company of … Continue Reading
It’s no secret that while some U.S. hospitals are thriving, others are struggling under the weight of decreasing reimbursement, rising expenses and pressures relative to integrated care.
One source of pressure that hits hospitals particularly dependent on Medicare/Medicaid reimbursement was … Continue Reading
PE firm Carlyle Group has announced it has agreed to acquire Johnson & Johnson’s Ortho Clinical Diagnostics business for $4.15 billion.
The transaction is expected to close in the middle of 2014.
Ortho Clinical Diagnostics, headquartered in Raritan, N.J., … Continue Reading
Ivantis, Inc. has announced it has raised $46.5 million in series B financing.
Ivantis designs, develops and commercializes technologies to treat glaucoma. It is the developer of the Hydrus microstent device designed to lower eye pressure for glaucoma patients.
Ivantis … Continue Reading
In our most recent Law360 column, we tackled a series of basic investment premises and common misconceptions about investing in the ambulatory surgery center (ASC) industry. This month’s column was co-authored with our McGuireWoods partner Bart Walker and is available … Continue Reading
Metabolon, Inc. has announced it has raised $15 million in a series E financing.
Metabolon, headquartered in Research Triangle Park, N.C., provides metabolomics-based diagnostic tests and research services.
New investor Camden Partners, a Baltimore-based PE firm, led the … Continue Reading
Mederi Therapeutics Inc. has announced it has secured $18.5 million in funding comprised of Series B preferred stock and venture debt.
Mederi Therapeutics, based in Greenwich, Conn., manufactures and markets medical devices that deliver radiofrequency energy to treat disease.… Continue Reading
Reuters is reporting that PE firm Carlyle Group LP is close to acquiring Johnson & Johnson’s blood-testing unit.
The deal could be finalized within the next two weeks and worth around $4 billion.
Caryle has struck a number of … Continue Reading
ViewRay Inc. has announced it has secured $30 million in funding.
ViewRay, based in Cleveland, Ohio, is a privately held medical device company developing advanced radiation therapy technology for the treatment of cancer.
The funding came from existing equity … Continue Reading
Consolidation of major healthcare providers in various sectors is not a new phenomenon, but 2013 saw a number of major hospital system mergers that was unusual for the sheer volume of hospitals and dollars involved.
An article from our partner … Continue Reading
CMS has announced it will extend the federal programs to encourage hospitals and physicians to adopt electronic health records — with Stage 2 now starting in 2015 and continuing through 2016, and Stage 3 beginning in 2017 for providers that … Continue Reading
Xlumena, Inc., has announced it has closed $25 million in Series C financing.
Xlumena, headquartered in Mountain View, Calif., is a developer of image-guided therapeutic endoscopy products.
The financing round included existing investors Prism VentureWorks, Charter Life Sciences, Ascent … Continue Reading
We are increasingly seeing attention on physician compensation issues, especially in light of the increased consolidation of physician practices into hospital systems. Setting appropriate compensation is a critical compliance issue for the hospital and physicians. The recent ruling by the … Continue Reading
Investors in the dialysis industry have been awaiting the final rule on the End-Stage Renal Disease (ESRD) Prospective Payment System, which was finally released on November 22.
The rule sets a base reimbursement rate of $239.02 per dialysis treatment for … Continue Reading